关注
Joshua Kapere Ochieng, PhD
Joshua Kapere Ochieng, PhD
Research Scientist, UT Health, MD Anderson Cancer Center
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers
DH Peng, BL Rodriguez, L Diao, PO Gaudreau, A Padhye, JM Konen, ...
Nature communications 12 (1), 2606, 2021
632021
Sox2 Regulates the Emergence of Lung Basal Cells by Directly Activating the Transcription of Trp63
JK Ochieng, K Schilders, H Kool, A Boerema-De Munck, ...
American journal of respiratory cell and molecular biology 51 (2), 311-322, 2014
602014
Hypoxia inducible factor 3α plays a critical role in alveolarization and distal epithelial cell differentiation during mouse lung development
Y Huang, J Kapere Ochieng, MB Kempen, AB Munck, S Swagemakers, ...
PLoS One 8 (2), e57695, 2013
402013
Augmented Lipocalin-2 is Associated with COPD and Counteracts Lung Adenocarcinoma Development
Am J Respir Crit Care Med, 2020
29*2020
Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage‐specific gene Gprc5a
J Fujimoto, S Nunomura‐Nakamura, Y Liu, W Lang, T McDowell, ...
International journal of cancer 141 (8), 1589-1599, 2017
292017
Dual inhibition of MEK and AXL targets tumor cell heterogeneity and prevents resistant outgrowth mediated by the epithelial-to-mesenchymal transition in NSCLC
JM Konen, BL Rodriguez, A Padhye, JK Ochieng, L Gibson, L Diao, ...
Cancer research 81 (5), 1398-1412, 2021
252021
Next-generation immunotherapies to improve anticancer immunity
Y Shi, K Tomczak, J Li, JK Ochieng, Y Lee, C Haymaker
Frontiers in pharmacology 11, 566401, 2021
202021
MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs
JK Ochieng, ST Kundu, R Bajaj, B Leticia Rodriguez, JJ Fradette, ...
Oncogene 39 (43), 6719-6732, 2020
192020
Differentiated type II pneumocytes can be reprogrammed by ectopic Sox2 expression
J Kapere Ochieng, K Schilders, H Kool, M Buscop-van Kempen, ...
PLoS One 9 (9), e107248, 2014
172014
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer
A Padhye, JM Konen, BL Rodriguez, JJ Fradette, JK Ochieng, L Diao, ...
JCI insight 6 (17), 2021
162021
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance
BL Rodriguez, L Chen, Y Li, S Miao, DH Peng, JJ Fradette, L Diao, ...
Frontiers in immunology 14, 1161869, 2023
62023
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial
MT Campbell, V Balderrama-Brondani, C Jimenez, G Tamsen, LP Marcal, ...
The Lancet Oncology 25 (5), 649-657, 2024
52024
Host lipocalin 2 protects against Kras mutant lung cancer development by maintaining an anti-tumor immune contexture
M Hassane, W Treekitkarnmongkol, TL McDowell, S Sivakumar, W Lang, ...
Cancer Research 79 (13_Supplement), 4952-4952, 2019
12019
Role of SOX2 in foregut development in relation to congenital abnormalities
K Schilders, JK Ochieng, CP van de Ven, C Gontan, D Tibboel, RJ Rottier
World Journal of Medical Genetics 4 (4), 94-104, 2014
12014
Changes in circulating immune biomarkers following nivolumab with or without ipilimumab for metastatic anal cancer (NCI9673).
VK Morris, J Ochieng, KK Ciombor, BN Polite, S Mukherjee, JC Krauss, ...
Journal of Clinical Oncology 42 (3_suppl), 3-3, 2024
2024
Targeting immunosuppressive classical monocytes prevents immunotherapy resistance
BL Rodriguez, L Chen, Y Li, S Miao, DH Peng, J Fradette, L Diao, ...
2022
MBIP promotes cell motility and metastasis in Kras/p53 mutant non-small cell lung cancer
JK Ochieng
8th Annual Postdoctoral Science Symposium, 51, 2018
2018
Development of Kras mutant lung adenocarcinoma in tobacco carcinogen exposed mice with knockout of the airway lineage-specific G-protein coupled receptor Gprc5a
J Fujimoto, S Nunomura, W Lang, Y Liu, J Wei, J Ochieng, Y Jakubek, ...
Cancer Research 76 (14_Supplement), 4056-4056, 2016
2016
Identifying Sox2 interaction partners in the developing lung
K Schilders
2016
Expression of the lipocalin 2 oncogene in the development of smoking-associated and Kras mutant lung adenocarcinoma
JFHK Joshua Ochieng, Sayuri Nunomura, Wenhua Lang, Jinsong Wei, Li Xu ...
107th AACR 76 (14), 1124, 2016
2016
系统目前无法执行此操作,请稍后再试。
文章 1–20